NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,671 | -60.2% | 5,300 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $14,245 | -12.2% | 5,500 | +38.3% | 0.00% | 0.0% |
| Q1 2023 | $16,222 | -65.3% | 3,976 | -57.3% | 0.00% | -66.7% |
| Q4 2022 | $46,776 | +679.6% | 9,318 | +1664.8% | 0.00% | – |
| Q3 2022 | $6,000 | -92.1% | 528 | -91.1% | 0.00% | -100.0% |
| Q2 2022 | $76,000 | +261.9% | 5,932 | +315.7% | 0.01% | +250.0% |
| Q1 2022 | $21,000 | -77.2% | 1,427 | -72.6% | 0.00% | -71.4% |
| Q4 2021 | $92,000 | +217.2% | 5,200 | +271.4% | 0.01% | +250.0% |
| Q3 2021 | $29,000 | +383.3% | 1,400 | +600.0% | 0.00% | +100.0% |
| Q4 2020 | $6,000 | +500.0% | 200 | +143.9% | 0.00% | – |
| Q2 2020 | $1,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |